Long/short equity, biotech, healthcare, small-cap

Why Medidata Is A Good Bet?

Medidata Solutions (NASDAQ:MDSO) is a pioneer in providing cloud-based clinical development solutions designed to improve the efficiency of the clinical development process. Through its primary offering, Medidata Rave, the company combines electronic data capture, or EDC, with a clinical data management system, or CDMS, in a comprehensive platform. This replaces the traditional paper-based methods. This technology platform is accessible and can be implemented on a single and multi-enterprise study basis. Medidata's customers include pharmaceutical, biotechnology, medical device companies, and other customers engaged in clinical trials for medical products. It has a larger market to service and other players have lower penetration levels. As observed in the recently announced quarter results, these factors are helping the company to grow...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details